Paper7547697
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
Mingari MC and 6 others. Int Immunol, 1995. Cited by 206 papers, by iCite.
Cite this record
ConductScience Library. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Papers, record 7547697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7547697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Histocompatibility Antigens Class I | Major topic |
| Killer Cells, Natural | Major topic |
| Lymphokines | Major topic |
| Receptors, Antigen, T-Cell | Major topic |
| Receptors, Immunologic | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Clone Cells | |
| Cytotoxicity Tests, Immunologic | |
| HLA-B Antigens | |
| Humans | |
| Receptors, KIR | |
| Receptors, KIR2DL3 |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793134 | NKR-P1A/CD161: A Multifunctional Immune Receptor at the Crossroads of Antitumor Immunity. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793134 | PubMed |
| 35036073 | Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/35036073 | PubMed |
| 34966390 | Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets. | Front Immunol | 2021 | https://conductscience.org/library/papers/34966390 | PubMed |
| 34559552 | Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34559552 | PubMed |
| 34349169 | Deciphering the biology of KIR2DL3+ T lymphocytes that are associated to relapse in haploidentical HSCT. | Sci Rep | 2021 | https://conductscience.org/library/papers/34349169 | PubMed |
| 34153005 | Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34153005 | PubMed |
| 33870131 | Role of NKG2a/c+CD8+ T cells in pathogenic versus non-pathogenic SIV infections. | iScience | 2021 | https://conductscience.org/library/papers/33870131 | PubMed |
| 33603738 | Gamma/Delta T Cells in the Course of Healthy Human Pregnancy: Cytotoxic Potential and the Tendency of CD8 Expression Make CD56+ γδT Cells a Unique Lymphocyte Subset. | Front Immunol | 2020 | https://conductscience.org/library/papers/33603738 | PubMed |
| 32335915 | Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/32335915 | PubMed |
| 32165419 | Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32165419 | PubMed |
| 31231370 | Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231370 | PubMed |
| 30778167 | Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. | Cell Mol Immunol | 2019 | https://conductscience.org/library/papers/30778167 | PubMed |
| 29895693 | Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29895693 | PubMed |
| 20722764 | The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. | Immunology | 2010 | https://conductscience.org/library/papers/20722764 | PubMed |
| 20634877 | The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20634877 | PubMed |
| 20067541 | Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming. | Immunology | 2009 | https://conductscience.org/library/papers/20067541 | PubMed |
| 18706662 | T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. | J Neurol Sci | 2008 | https://conductscience.org/library/papers/18706662 | PubMed |
| 16412060 | NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/16412060 | PubMed |
| 14562047 | Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. | Oncogene | 2003 | https://conductscience.org/library/papers/14562047 | PubMed |
| 12960383 | HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12960383 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDK11B | 984 | PubTator's text mining | https://conductscience.org/library/genes/984 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| KLRD1 | 3824 | PubTator's text mining | https://conductscience.org/library/genes/3824 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7547697
GET https://conductscience.org/api/papers/v1/7547697/cited_by?page=2